期刊文献+

孟鲁司特对不同阶段大鼠气管平滑肌细胞Ⅲ型胶原蛋白功能的影响 被引量:1

Effect of Montelukast on the Type Ⅲ Collagen in Rat Airway Smooth Muscle Cells at Different Stages
下载PDF
导出
摘要 目的:探讨大鼠哮喘气道重塑过程中不同阶段气管平滑肌细胞(ASMC)分泌的Ⅲ型胶原蛋白功能的变化及孟鲁司特对Ⅲ型胶原蛋白的影响。方法:应用卵蛋白致敏激发建立哮喘气道重塑大鼠模型,原代培养ASMC,通过免疫组织化学方法检测ASMC中Ⅲ型胶原蛋白的表达。结果:哮喘组Ⅲ型胶原蛋白平均灰度值均高于对照组,以卵蛋白激发8周组最高,差异有统计学意义(P均<0.01);孟鲁司特干预组Ⅲ型胶原蛋白平均灰度值明显低于哮喘气道重塑组,尤以孟鲁司特干预2周及4周组差异更显著(P<0.01)。结论:孟鲁司特通过抑制ASMC分泌的Ⅲ型胶原蛋白合成能力而减轻气道重塑。 Objective:To investigate the effect of montelukast on the secretion of type Ⅲ collagen in airway smooth muscle cells(ASMC) during different stages of airway remodeling in asthmatic rats.Methods:Ovalbumin(OVA) was used to establish asthmatic airway remodeling model of SD rats and montelukast was given to interfere.Primary culture purified ASMC,and measured the expression of type Ⅲ collagen in ASMC by immunochemical method.Results:The average gray value of type Ⅲ collagen in asthma group was higher than that of the control group,and OVA motivated 8 weeks group was the highest.The differences were significant(P〈0.01).The average gray value of type Ⅲ collagen in montelukast group was significantly lower than that in asthmatic airway remodeling group,it was significantly different in 2 weeks group and 4 weeks group(P〈0.01).Conclusion:Montelukast can reduce airway remodeling by inhibiting ASMC collagen synthesis ability.
出处 《儿科药学杂志》 CAS 2018年第2期1-4,共4页 Journal of Pediatric Pharmacy
基金 辽宁省科学技术计划面上项目 编号2015020444
关键词 哮喘 气道重塑 气管平滑肌细胞 Ⅲ型胶原蛋白 孟鲁司特 asthma airway remodeling airway smooth muscle cell type Ⅲ collagen montelukast
  • 相关文献

参考文献2

二级参考文献18

  • 1李淼,尚云晓.哮喘豚鼠气道内NK-1R mRNA表达及其含量的研究[J].中国医科大学学报,2005,34(6):502-502. 被引量:5
  • 2Payne DN,Rogers AV,Adelroth E,et al.Early thickening of thereticular basement membrane in children with difficult asthma[J].Am J Respir Crit Care Med,2003,67(1):78-82.
  • 3Fedorov IA,Wilson SJ,Davies DE,et al.Epithelial stress andstructural remodelling in childhood asthma[J].Thorax,2005,60(5):389-394.
  • 4Muz MH,Deveci F,Bulut Y,et al.The effects of low doseleukotriene receptor antagonist therapy on airway remodeling andcysteinyl leukotriene expression in a mouse asthma model[J].Exp Mol Med,2006,38(2):109-118.
  • 5Murai A,Abe M,Hayashi Y,et al.Comparison study betweenthe mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast andmethylprednisolone[J].J Pharmacol Exp Ther,2005,312(2):432-440.
  • 6魏兵,尚云晓,李淼,张晗,李娜.吸入布地奈德对幼年大鼠气道重塑的影响[J].中国美容医学,2011,20(6):76-78.
  • 7Tagaya E, Tamaoki J. Mechanisms of airway remodeling in asthma [J]. Allergol Int,2007,56(4) :331-340.
  • 8Epstein MM. Do mouse models of allergic asthma mimic clinical disease? [ J]. Int Arch Allergy Immunol,2004,133 (1) :84-100.
  • 9Warner SM, Knight DA . Airway modeling and remodeling in the pathogenesis of asthma [ J ]. Curr Opin Allergy Clin Immunol, 2008,8( 1 ) :44-48.
  • 10Groneberg DA, Harrison S, Dinh QT, et al. Taehykinins in the re- spiratory tract[ J]. Curt Drug Targets, 2006,7 (8) : 1005-1010.

共引文献12

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部